RESEARCH
Meta-analysis evaluates ctDNA-guided adjuvant chemotherapy in resectable colorectal cancerA systematic review of cohort studies from January 2010 to July 2026 assessed the efficacy of circulating tumor DNA-guided adjuvant chemotherapy in patients with resectable colorectal cancer, reporting recurrence-free survival and overall survival outcomes. (Oncology Letters)